Generic Name: N/A
Drug Class: NAFLD/NASH Medications
Company: Gilead Sciences
Approval Status: Experimental
Generic Version Available: No
Experimental Code: GS-0976
General Info
Firsocostat is an acetyl-CoA carboxylase (ACC) inhibitor in Phase 2 clinical trials for treatment of non-alcoholic steatohepatitis (NASH).
Dosage
Dosing Info: N/A
Side Effects
N/A
Last Reviewed: February 4, 2019
